Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US (NCT07431086)
A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Pharmacokinetics, Safety, Tolerability, and Efficacy of Olatorepatide, a GLP-1/GIP Receptor Agonist, in Participants Living With Overweight or Obesity in the US
🩺 Plain-English Summary (8th-Grade Level)
This study will test olatorepatide (study drug) to determine how safe and effective this drug is and how easily your body can accept this drug without causing side effects, as well as how the drug is processed in the body by participants with overweight or obesity. The study will test how safe and effective the study drug works compared to placebo in people who are overweight or obese but do not have diabetes. The study is looking at: * What side effects the study drug might cause * How much the study drug is in the blood at different times * How well the study drug works * If the body makes antibodies to the study drug as this may cause the study drug to not work as well
Who can join: Review the eligibility criteria below.
Location: Diablo Clinical Research - Flourish Research — Walnut Creek, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Diablo Clinical Research - Flourish Research — Walnut Creek, California
- Clinical Site Partners, LLC DBA Flourish Research — Winter Park, Florida
- Flourish Research - San Antonio Medical Trials — San Antonio, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight or Obesity
- A Study of LY4064912 in Healthy Participants and With Overweight or Obesity — Los Alamitos, California
- PA Moves Trial - Patient Participants — Pittsburgh, Pennsylvania
- Berries, Inflammation, and Gut Microbiome — Chicago, Illinois
- Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women — Birmingham, Alabama
- The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control — Halifax, Nova Scotia
Explore by condition: All Overweight or Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.